electroCore, Inc. (ECOR)

6,58 +0,51 (+8,40%) In data: 12:52PM EDT. Mercato aperto.

electroCore, Inc.

200 Forge Way
Suite 205
Rockaway, NJ 07866
United States
973 290 0097
https://www.electrocore.com

Settore/i: Healthcare
Settore: Medical Devices
Impiegati a tempo pieno: 68

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Mr. Daniel S. Goldberger	CEO & Director	1,05M	N/D	1959
Dr. Thomas J. Errico M.D.	Founder, Independent Director & Principal Investor	58,12k	N/D	1952
Mr. Brian M. Posner CPA, MBA.	CFO & Corporate Secretary	599,88k	N/D	1962
Mr. Michael Romaniw	Executive Vice President of Systems & Operations	N/D	N/D	1957
Mr. Mitch Deshon	Vice President of Global Sales & Business Development	N/D	N/D	N/D
Ms. Carrie Kochek	Senior Director of Human Resources	N/D	N/D	N/D
Dr. Peter S. Staats M.B.A., M.D.	Chief Medical Officer	238,41k	N/D	1964
Mr. Joshua S. Lev	Chief Strategy Officer	N/D	N/D	N/D
Mr. Manuel A. Marques	Senior Vice President of Operations	N/D	N/D	1973
Ms. Amanda Yanuklis	Chief of Staff	N/D	N/D	N/D

Gli importi risalgono al giorno 31 dicembre 2023 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.

Descrizione

electroCore, Inc., a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga for the support of general health and wellbeing; and TAC-STIM for human performance. In addition, the company offers gammacore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.

Governance aziendale

L'ISS Governance QualityScore di electroCore, Inc. al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.